Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

A case study on how DelveInsight supported a client with a focused CAR-TCR Summit coverage plan to gain exclusive insights into CAR-T therapies for B-cell malignancies.New York, USA, Feb. 21, 2025 (GL ...

According to the American Cancer Society, B-cell lymphoma is a type of cancer that develops in B-lymphocytes. B-cell lymphomas account for the vast majority of non-Hodgkin lymphomas. Every year ...

Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.

a transcription factor involved in B lymphocyte (B cell) development that frequently is mutated in B cell precursor acute lymphoblastic leukemia (B-ALL), a common pediatric cancer. B cells create ...

About 80% of the lymphocytes are T cells; the remaining 20% are B cells, but up to 5% may be NK cells. In general, very few basophils or eosinophils circulate in the blood. WBCs of every kind ...

Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...

Corticosteroids inhibit antigen presentation, cytokine production, and proliferation of lymphocytes ... such as amphotericin B, may enhance the potassium-wasting effect of corticosteroids.